These tumor cells uniquely express MHC class II molecules, typically restricted to antigen‐presenting cells, and correlate with immune checkpoint activation and PD‐L1 expression, potentially contributing to an immunosuppressive microenvironment specific to HBV+HCC. Here, CD274 is linked to neoplasm.